VF
AXSM icon

Virtu Financial’s Axsome Therapeutics AXSM Stock Holding History

Virtu Financial’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Buy
+9,220
New +$2M 0.07% 164
2026
Q1 		– Sell
-15,573
Closed -$2.84M – 1634
2025
Q4 		$2.84M Buy
+15,573
New +$2.17M 0.11% 97
2025
Q2 		– Sell
-7,986
Closed -$931K – 1449
2025
Q1 		$931K Buy
+7,986
New +$910K 0.05% 296
2023
Q4 		– Sell
-13,686
Closed -$956K – 1565
2023
Q3 		$956K Sell
13,686
-15,893
-54% -$1.19M 0.1% 185
2023
Q2 		$2.13M Buy
29,579
+23,508
+387% +$1.73M 0.16% 99
2023
Q1 		$374K Buy
+6,071
New +$399K 0.04% 450
2022
Q4 		– Sell
-9,466
Closed -$422K – 1595
2022
Q3 		$422K Buy
9,466
+1,111
+13% +$55.5K 0.04% 475
2022
Q2 		$320K Buy
+8,355
New +$264K 0.03% 553
2021
Q4 		– Sell
-20,292
Closed -$669K – 1706
2021
Q3 		$669K Buy
+20,292
New +$791K 0.06% 343
2021
Q2 		– Sell
-5,940
Closed -$336K – 1509
2021
Q1 		$336K Buy
+5,940
New +$418K 0.02% 749
2020
Q4 		– Sell
-12,320
Closed -$878K – 1428
2020
Q3 		$878K Buy
12,320
+6,336
+106% +$494K 0.15% 147
2020
Q2 		$492K Buy
+5,984
New +$461K 0.06% 380
2018
Q3 		– Sell
-18,609
Closed -$60K – 1535
2018
Q2 		$60K Buy
+18,609
New +$57.7K ﹤0.01% 1727

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Virtu Financial's AXSM Position: Q2 2026 in Review

Virtu Financial opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 9,220 shares worth $2.26M. The stake represents 0.07% of the portfolio and ranks #164 among its holdings. This is a return to the name: Virtu Financial previously reported a position in AXSM as recently as Q4 2025.

Virtu Financial first reported a position in AXSM in Q2 2018 and has held it in 13 quarters since. The position peaked at $2.84M in Q4 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Virtu Financial held 9,220 shares of Axsome Therapeutics worth $2.26M as of Q2 2026.
  • Axsome Therapeutics was a new Virtu Financial position in Q2 2026.
  • Axsome Therapeutics made up 0.07% of Virtu Financial's portfolio in Q2 2026, its #164 holding.
  • Virtu Financial first reported a position in Axsome Therapeutics in Q2 2018 and has held it in 13 quarters since.
  • Virtu Financial's Axsome Therapeutics position peaked at $2.84M in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.